Kit and method for detecting myositis and myasthenia gravis autoantibodies in human body fluid
A myasthenia gravis and autoantibody technology, applied in the field of biomedicine, can solve the problems of time-consuming detection process, large antibody demand, and low detection sensitivity, and achieve the effects of short detection cycle, reduced pollution, and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0091] The target antigen Ag in the detection kit of the present invention can be obtained by the prior art, and can also be obtained by the following method of the present invention, preferably the preparation method of the present invention. Specifically, the preparation method of the material for detecting myositis and myasthenia gravis autoantibody in human body fluid of the present invention includes the following steps:
[0092] Step 1. Obtain the CDS sequence of the target antigen Ag as the target gene, insert the target gene with the restriction site into the pET28a plasmid vector to obtain the recombinant plasmid vector pET28a-Ag; Ag represents the autoantibody corresponding to myositis and myasthenia gravis disease One of the target antigens;
[0093] Step 1.1: Obtain the CDS sequence of the autoantibody target antigen Ag by artificial synthesis or PCR as the target gene, and add NheI / NotI restriction sites at both ends of the target gene;
[0094] Step 1.2, insert the tar...
Embodiment 1
[0127] This example discloses a preparation method of a detection material for myositis and myasthenia gravis autoantibodies in human body fluid. The target antigen in this example is the target antigen MDA5 for myositis disease, and the negative control antigen is GAPDH. The preparation method is specific include:
[0128] 1. Plasmid construction:
[0129] Obtain the CDS sequence of autoantibody target antigen HuB and GAPDH by artificial synthesis or PCR method as the target gene, and add NheI / NotI restriction sites at both ends of the target gene;
[0130] Insert the target gene with restriction site into the pET28a vector, the insertion site is NheI / NotI, to obtain the recombinant vector, the recombinant vector is named pET28a-HuB and pET28a-GAPDH, specifically:
[0131] The glycerol strain of pET28a plasmid was inoculated into 3mL LB liquid medium resistant to kanamycin, and placed in a 37°C constant temperature incubator, 220r / min, overnight shaking. On the second day, 500 μL of...
Embodiment 2
[0150] This embodiment discloses a detection kit, which includes a test strip, a working solution and a blocking protein solution;
[0151] The test strip is the test strip corresponding to the target antigen in Example 1. Specifically, the test strip includes a backing plate, a carrier film provided with a control line and a test line, an absorbent pad, a sample pad and a gold label pad; carrier film detection The target antigen Ag is solidified on the dot, and Ag represents one of the target antigens corresponding to autoantibodies of myositis and myasthenia gravis disease; a negative control antigen is solidified on the control line. The absorbent pad, carrier film, sample pad, and gold-labeled pad are all laid on the pad, the absorbent pad is set at the end of the carrier film control line, and the sample pad or gold-labeled pad is set at the end of the carrier film detection point, such as figure 1 , figure 2 Shown.
[0152] Among them, the working solution is a mixed solutio...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com